Cytokine profile of Pno lymphocytes and patient PBLs
PMA3-150 . | IL-2 (pg/mL) . | IL-4 (pg/mL) . | IFN-γ (U/mL) . | IL-10 (pg/mL) . | TNF-α (pg/mL) . | TGF-β1 (pg/mL) . |
---|---|---|---|---|---|---|
Pno | ||||||
Medium | <10 | <10 | <0.1 | <10 | 30 | 40 |
Anti-CD3 mAb | 44 | 48 | <0.1 | <10 | 118 | 523 |
Patient PBL | ||||||
Medium | <10 | <10 | <0.1 | <10 | <10 | <10 |
Anti-CD3 mAb | 67 | 26 | <0.1 | <10 | 54 | 244 |
PMA3-150 . | IL-2 (pg/mL) . | IL-4 (pg/mL) . | IFN-γ (U/mL) . | IL-10 (pg/mL) . | TNF-α (pg/mL) . | TGF-β1 (pg/mL) . |
---|---|---|---|---|---|---|
Pno | ||||||
Medium | <10 | <10 | <0.1 | <10 | 30 | 40 |
Anti-CD3 mAb | 44 | 48 | <0.1 | <10 | 118 | 523 |
Patient PBL | ||||||
Medium | <10 | <10 | <0.1 | <10 | <10 | <10 |
Anti-CD3 mAb | 67 | 26 | <0.1 | <10 | 54 | 244 |
PMA was used at a final concentration of 2 ng/mL.